Long-term L-4F treatment has also been previously reported to have beneficial cardiac functional effects in a genetic type II diabetes mouse model, which were attributed to decreased systemic pro-inflammatory cytokines and increased myocardial expression of heme oxygenase-1 [31]. This evidence concerns the gene HMOX1 and type 2 diabetes mellitus.